AIG
HARP

American International Group’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

American International Group’s Portfolio HARP Stock Details HARP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-929
Closed -$46K – 3342
2022
Q1 		$46K Sell
929
-65
-7% -$3.37K ﹤0.01% 2876
2021
Q4 		$75K Sell
994
-30
-3% -$2.05K ﹤0.01% 2834
2021
Q3 		$81K Sell
1,024
-24
-2% -$2.41K ﹤0.01% 2875
2021
Q2 		$145 Buy
1,048
+258
+33% +$49.2K ﹤0.01% 2709
2021
Q1 		$165 Buy
790
+166
+27% +$33.3K ﹤0.01% 2467
2020
Q4 		$104 Sell
624
-8
-1% -$1.24K ﹤0.01% 2646
2020
Q3 		$107K Sell
632
-15
-2% -$2.16K ﹤0.01% 2497
2020
Q2 		$107K Buy
647
+213
+49% +$33.2K ﹤0.01% 2499
2020
Q1 		$50K Sell
434
-25
-5% -$3.52K ﹤0.01% 2685
2019
Q4 		$68K Buy
459
+1
+0.2% +$152 ﹤0.01% 2798
2019
Q3 		$63K Buy
458
+81
+21% +$11.4K ﹤0.01% 2826
2019
Q2 		$49K Buy
377
+213
+130% +$24.8K ﹤0.01% 2950
2019
Q1 		$15K Buy
+164
New +$21.6K ﹤0.01% 3014

Other funds holding HARP

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

American International Group's HARP Position: Q2 2022 in Review

American International Group sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q2 2022, closing a stake of 929 shares — an estimated $46K sold.

American International Group first reported a position in HARP in Q1 2019 and held it in 13 quarters. The position peaked at $107K in Q3 2020. 63 funds tracked by Wall St. Rank hold HARP as of Q2 2022.

  • American International Group reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • American International Group sold 929 Harpoon Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $46K.
  • American International Group first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q1 2019 and held it in 13 quarters.
  • American International Group's Harpoon Therapeutics, Inc. Common Stock position peaked at $107K in Q3 2020.
  • 63 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q2 2022.

Based on American International Group's 13F filing for Q2 2022, filed 12 Aug 2022.